首页 > 最新文献

Casopis lekaru ceskych最新文献

英文 中文
How to feed patients with obesity in intensive care? 重症监护中肥胖患者如何喂养?
Q4 Medicine Pub Date : 2025-01-01
Jarmila Křížová, Zuzana Kršáková

In connection with the increasing prevalence of overweight and obesity, the number of these patients in intensive care units is increasing - current statistics indicate 20-30% of patients admitted in the obesity zone and 25% in the overweight zone. Nutritional goals and strategies for patients with obesity are one of the biggest challenges of modern nutritional care. They include a comprehensive diagnosis of malnutrition and the correct determination of energy and protein intake, for which it is possible to use formulas recommended by the European Society for Parenteral and Enteral Nutrition (ESPEN) or the American Society for Parenteral and Enteral Nutrition (ASPEN). The research focuses on the possibilities of immunonutrition and influencing the microbiota.

随着超重和肥胖患病率的增加,重症监护病房的这些患者数量也在增加——目前的统计数据表明,20-30%的患者住在肥胖区,25%住在超重区。肥胖患者的营养目标和策略是现代营养护理的最大挑战之一。它们包括对营养不良的全面诊断和对能量和蛋白质摄入量的正确测定,为此可以使用欧洲肠外和肠内营养学会(ESPEN)或美国肠外和肠内营养学会(ASPEN)推荐的配方。研究的重点是免疫营养和影响微生物群的可能性。
{"title":"How to feed patients with obesity in intensive care?","authors":"Jarmila Křížová, Zuzana Kršáková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In connection with the increasing prevalence of overweight and obesity, the number of these patients in intensive care units is increasing - current statistics indicate 20-30% of patients admitted in the obesity zone and 25% in the overweight zone. Nutritional goals and strategies for patients with obesity are one of the biggest challenges of modern nutritional care. They include a comprehensive diagnosis of malnutrition and the correct determination of energy and protein intake, for which it is possible to use formulas recommended by the European Society for Parenteral and Enteral Nutrition (ESPEN) or the American Society for Parenteral and Enteral Nutrition (ASPEN). The research focuses on the possibilities of immunonutrition and influencing the microbiota.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"110-112"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol-related liver disease. 与酒精有关的肝病。
Q4 Medicine Pub Date : 2025-01-01
Eva Mayerová

Alcohol-related liver disease (ALD) represents a broad continuum of pathological conditions caused by excessive alcohol consumption - from simple steatosis through steatohepatitis and fibrosis to cirrhosis and its complications. The article summarizes the current view on this issue.

酒精相关性肝病(ALD)是由过量饮酒引起的一系列广泛的病理状况——从单纯的脂肪变性到脂肪性肝炎和纤维化,再到肝硬化及其并发症。文章总结了目前对这一问题的看法。
{"title":"Alcohol-related liver disease.","authors":"Eva Mayerová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Alcohol-related liver disease (ALD) represents a broad continuum of pathological conditions caused by excessive alcohol consumption - from simple steatosis through steatohepatitis and fibrosis to cirrhosis and its complications. The article summarizes the current view on this issue.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"299-305"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
80 years of the Institute of Physiology. 生理学研究所成立80年了。
Q4 Medicine Pub Date : 2025-01-01
Zuzana Červinková, Otto Kučera
{"title":"80 years of the Institute of Physiology.","authors":"Zuzana Červinková, Otto Kučera","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"191-196"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurosurgery in Hradec Králové - from a rich past to the present day. 赫拉代克的神经外科Králové -从丰富的过去到现在。
Q4 Medicine Pub Date : 2025-01-01
Tomáš Česák, Tomáš Hosszú, Jiří Náhlovský, Petr Krůpa
{"title":"Neurosurgery in Hradec Králové - from a rich past to the present day.","authors":"Tomáš Česák, Tomáš Hosszú, Jiří Náhlovský, Petr Krůpa","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"227-232"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern approaches enhancing the efficiency of antibiotic therapy in hospital practice. 现代方法提高了医院抗生素治疗的效率。
Q4 Medicine Pub Date : 2025-01-01
Lukáš Bauer, Jan Cihlo

The current effective antibiotic therapy requires modern approaches focused on optimizing treatment and slowing the growth of antimicrobial resistance. A key tool in hospitals is the concept of antimicrobial stewardship, which relies on collaboration in multidisciplinary teams composed of infectious disease specialists, microbiologists, clinical pharmacists, and epidemiologists. These teams focus on the correct choice of antibiotic and its dosage, monitoring its effectiveness and minimising adverse effects. Expanding possibilities in the field of monitoring and interpretation of plasma concentrations of an increasing number of antibiotics enable effective and safe optimization of dosing and administration methods (prolonged and continuous infusions) adjusted for individual patients, thereby allowing a personalized approach to pharmacotherapy. The optimization of antibiotic dosing is further supported using modern administration tools. In the hospital setting, electronic parametric prescribing, centralized preparation and dispensing of anti-infectives by the hospital pharmacy also leads to improved safety. In outpatient care, possibilities are expanding with the concept of outpatient parenteral antimicrobial therapy, which reduces the risk of nosocomial infections and provides the comfort of a home environment for patients. However, its broader use is hindered mainly by the lack of official stability data for antibiotic preparations, as well as administrative and financial barriers associated with integrating this innovative concept into routine practice.

目前有效的抗生素治疗需要现代方法,重点是优化治疗和减缓抗菌素耐药性的增长。医院的一个关键工具是抗微生物药物管理的概念,它依赖于由传染病专家、微生物学家、临床药剂师和流行病学家组成的多学科团队的合作。这些小组的重点是正确选择抗生素及其剂量,监测其有效性并尽量减少不良反应。越来越多的抗生素在监测和解释血浆浓度方面的可能性不断扩大,这使得针对个体患者调整的剂量和给药方法(长时间和连续输注)能够有效和安全地优化,从而允许采用个性化的药物治疗方法。使用现代给药工具进一步支持抗生素剂量的优化。在医院环境中,医院药房的电子参数处方,集中制备和分配抗感染药物也提高了安全性。在门诊治疗方面,随着门诊肠外抗菌药物治疗的概念,可能性正在扩大,这降低了医院感染的风险,并为患者提供了舒适的家庭环境。然而,它的广泛使用受到阻碍,主要是由于缺乏抗生素制剂的官方稳定性数据,以及将这一创新概念纳入常规实践的行政和财政障碍。
{"title":"Modern approaches enhancing the efficiency of antibiotic therapy in hospital practice.","authors":"Lukáš Bauer, Jan Cihlo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The current effective antibiotic therapy requires modern approaches focused on optimizing treatment and slowing the growth of antimicrobial resistance. A key tool in hospitals is the concept of antimicrobial stewardship, which relies on collaboration in multidisciplinary teams composed of infectious disease specialists, microbiologists, clinical pharmacists, and epidemiologists. These teams focus on the correct choice of antibiotic and its dosage, monitoring its effectiveness and minimising adverse effects. Expanding possibilities in the field of monitoring and interpretation of plasma concentrations of an increasing number of antibiotics enable effective and safe optimization of dosing and administration methods (prolonged and continuous infusions) adjusted for individual patients, thereby allowing a personalized approach to pharmacotherapy. The optimization of antibiotic dosing is further supported using modern administration tools. In the hospital setting, electronic parametric prescribing, centralized preparation and dispensing of anti-infectives by the hospital pharmacy also leads to improved safety. In outpatient care, possibilities are expanding with the concept of outpatient parenteral antimicrobial therapy, which reduces the risk of nosocomial infections and provides the comfort of a home environment for patients. However, its broader use is hindered mainly by the lack of official stability data for antibiotic preparations, as well as administrative and financial barriers associated with integrating this innovative concept into routine practice.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 1","pages":"3-8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of performance between artificial intelligence and radiologists in detecting abnormalities on chest X-rays. 人工智能和放射科医生在检测胸部x光异常方面的表现比较。
Q4 Medicine Pub Date : 2025-01-01
Jakub Dandár, Tomáš Jindra, Daniel Kvak

Artificial intelligence (AI) has been increasingly applied in radiology, where it offers the potential to improve the accuracy and efficiency of diagnosis, particularly in the evaluation of conventional imaging modalities such as chest X-rays. This study analyzes the performance of commercial software using machine learning and, respectively, artificial intelligence approaches (Carebot AI CXR; Carebot s.r.o.) in detecting abnormalities in chest radiographs compared with independent evaluations by 3 radiologists of different levels of experience. The study was conducted in collaboration with Hospital Tabor, which provided a dataset of 207 anonymised radiographs, out of which 196 were assessed as relevant. The sensitivity and specificity of AI were compared with human assessment in 5 categories of abnormalities: atelectasis (ATE), consolidation (CON), cardiac shadow enlargement (CMG), pleural effusion (EFF) and pulmonary lesions (LES). Carebot AI CXR software achieved high sensitivity in all evaluated categories (e.g., ATE: 0.909, CMG: 0.889, EFF: 0.951), and its performance was consistent across all findings. In contrast, AI specificity was lower in some categories (e.g., EFF: 0.792, CON: 0.895), while radiologists achieved performance values approaching 1.000 in most cases (e.g., RAD 1 and RAD 2 EFF: 1.000). AI demonstrated consistently higher sensitivity than less experienced radiologists (e.g., RAD 1 ATE: 0.087, CMG: 0.327) and in some cases than more experienced assessors, but at a modest decrease in specificity. The study also includes case reports, including false-positive and false-negative findings, which contribute to a deeper understanding of AI performance in clinical practice. The results suggest that AI can effectively complement the work of radiologists, especially for less experienced doctors, and improve the sensitivity of diagnosis on chest radiographs.

人工智能(AI)越来越多地应用于放射学,它提供了提高诊断准确性和效率的潜力,特别是在胸部x光等传统成像模式的评估中。本研究分别使用机器学习和人工智能方法(Carebot AI CXR;Carebot s.r.o.)在胸部x线片异常检测中的应用与3位不同经验水平的放射科医生的独立评估进行了比较。该研究是与塔博尔医院合作进行的,该医院提供了207张匿名x光片的数据集,其中196张被评估为相关。在肺不张(ATE)、实变(CON)、心影增大(CMG)、胸腔积液(EFF)和肺病变(LES) 5类异常情况下,比较人工智能的敏感性和特异性。Carebot AI CXR软件在所有评估类别中都具有高灵敏度(例如,ATE: 0.909, CMG: 0.889, EFF: 0.951),并且其性能在所有结果中都是一致的。相比之下,人工智能特异性在某些类别中较低(例如,EFF: 0.792, CON: 0.895),而放射科医生在大多数情况下达到接近1.000的性能值(例如,RAD 1和RAD 2 EFF: 1.000)。AI的敏感性始终高于经验不足的放射科医生(例如,RAD 1 ATE: 0.087, CMG: 0.327),在某些情况下也高于经验丰富的评估人员,但特异性略有下降。该研究还包括病例报告,包括假阳性和假阴性结果,这有助于更深入地了解人工智能在临床实践中的表现。结果表明,人工智能可以有效地补充放射科医生的工作,特别是对于经验不足的医生,并提高胸片诊断的敏感性。
{"title":"Comparison of performance between artificial intelligence and radiologists in detecting abnormalities on chest X-rays.","authors":"Jakub Dandár, Tomáš Jindra, Daniel Kvak","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Artificial intelligence (AI) has been increasingly applied in radiology, where it offers the potential to improve the accuracy and efficiency of diagnosis, particularly in the evaluation of conventional imaging modalities such as chest X-rays. This study analyzes the performance of commercial software using machine learning and, respectively, artificial intelligence approaches (Carebot AI CXR; Carebot s.r.o.) in detecting abnormalities in chest radiographs compared with independent evaluations by 3 radiologists of different levels of experience. The study was conducted in collaboration with Hospital Tabor, which provided a dataset of 207 anonymised radiographs, out of which 196 were assessed as relevant. The sensitivity and specificity of AI were compared with human assessment in 5 categories of abnormalities: atelectasis (ATE), consolidation (CON), cardiac shadow enlargement (CMG), pleural effusion (EFF) and pulmonary lesions (LES). Carebot AI CXR software achieved high sensitivity in all evaluated categories (e.g., ATE: 0.909, CMG: 0.889, EFF: 0.951), and its performance was consistent across all findings. In contrast, AI specificity was lower in some categories (e.g., EFF: 0.792, CON: 0.895), while radiologists achieved performance values approaching 1.000 in most cases (e.g., RAD 1 and RAD 2 EFF: 1.000). AI demonstrated consistently higher sensitivity than less experienced radiologists (e.g., RAD 1 ATE: 0.087, CMG: 0.327) and in some cases than more experienced assessors, but at a modest decrease in specificity. The study also includes case reports, including false-positive and false-negative findings, which contribute to a deeper understanding of AI performance in clinical practice. The results suggest that AI can effectively complement the work of radiologists, especially for less experienced doctors, and improve the sensitivity of diagnosis on chest radiographs.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 3","pages":"125-140"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144858958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern possibilities of diagnosis and treatment of Peyronie's disease in the Czech context. 现代诊断和治疗佩罗尼氏病在捷克的可能性。
Q4 Medicine Pub Date : 2025-01-01
Marek Broul, Aneta Hujová, Libor Zámečník

Peyronie's disease is an acquired fibrotic disorder of the tunica albuginea, leading to penile deformity, painful erections, and often erectile dysfunction; its prevalence in Europe reaches up to 9% in middle-aged men. This review summarizes the results of studies from 2019-2025 concerning diagnostic methods and therapeutic options. Based on the analysis of 142 original studies, 23 meta-analyses, and current European Association of Urology (EAU) a American Urological Association (AUA) recommendations, we confirm that intralesional verapamil reduces curvature in the active phase by an average of 9-17° and low-intensity shockwave therapy (LiSWT) improves pain and reduces curvature by approximately 10°, particularly for plaques larger than 2 cm. Surgical methods - plication, incision/grafting, and penile prosthesis implantation - achieve initial straightening in more than 90% of cases but differ in impact on penile length and the risk of de novo erectile dysfunction. Regenerative therapies like platelet-rich plasma (PRP) or mesenchymal stem cells (MSC) offer promising, yet currently experimental results. Optimal care is based on early diagnosis, individualization of conservative treatment, and precise surgical correction; in the Czech Republic, standard approaches include verapamil, LiSWT, and surgery, while biological approaches require further research.

佩罗尼氏病是一种获得性白膜纤维化疾病,可导致阴茎畸形、勃起疼痛和勃起功能障碍;在欧洲,中年男性的患病率高达9%。本文综述了2019-2025年关于诊断方法和治疗方案的研究结果。基于对142项原始研究、23项荟萃分析的分析,以及目前欧洲泌尿学会(EAU)和美国泌尿学会(AUA)的建议,我们证实病变内维拉帕米在活动期平均减少9-17°弯曲,低强度冲击波治疗(LiSWT)改善疼痛,减少弯曲约10°,特别是对于大于2 cm的斑块。手术方法-应用,切口/移植和阴茎假体植入-在90%以上的病例中实现了初始矫直,但对阴茎长度和新生勃起功能障碍的风险的影响有所不同。再生疗法,如富血小板血浆(PRP)或间充质干细胞(MSC)提供了有希望的,但目前的实验结果。最佳护理是基于早期诊断、个体化保守治疗和精确的手术矫正;在捷克共和国,标准方法包括维拉帕米、LiSWT和手术,而生物学方法需要进一步研究。
{"title":"Modern possibilities of diagnosis and treatment of Peyronie's disease in the Czech context.","authors":"Marek Broul, Aneta Hujová, Libor Zámečník","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Peyronie's disease is an acquired fibrotic disorder of the tunica albuginea, leading to penile deformity, painful erections, and often erectile dysfunction; its prevalence in Europe reaches up to 9% in middle-aged men. This review summarizes the results of studies from 2019-2025 concerning diagnostic methods and therapeutic options. Based on the analysis of 142 original studies, 23 meta-analyses, and current European Association of Urology (EAU) a American Urological Association (AUA) recommendations, we confirm that intralesional verapamil reduces curvature in the active phase by an average of 9-17° and low-intensity shockwave therapy (LiSWT) improves pain and reduces curvature by approximately 10°, particularly for plaques larger than 2 cm. Surgical methods - plication, incision/grafting, and penile prosthesis implantation - achieve initial straightening in more than 90% of cases but differ in impact on penile length and the risk of de novo erectile dysfunction. Regenerative therapies like platelet-rich plasma (PRP) or mesenchymal stem cells (MSC) offer promising, yet currently experimental results. Optimal care is based on early diagnosis, individualization of conservative treatment, and precise surgical correction; in the Czech Republic, standard approaches include verapamil, LiSWT, and surgery, while biological approaches require further research.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 6","pages":"262-268"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol and the cardiovascular system. 酒精和心血管系统
Q4 Medicine Pub Date : 2025-01-01
Jitka Mlíková Seidlerová

Mlíková Seidlerová J. Alcohol and the cardiovascular system The consumption of alcohol leads to a variety of direct and indirect effects on the cardiovascular system, as evidenced by numerous epidemiological studies on this topic. The effect of alcohol on the development of cardiovascular complications is influenced not only by the amount of alcohol consumed but also by the drinking pattern (binge drinking vs. regular consumption of moderate amounts of alcohol). This applies to the relationship between alcohol consumption and the rise in blood pressure or the development of arterial hypertension as well.

Mlíková seidlerov酒精和心血管系统酒精的消耗会对心血管系统产生各种直接和间接的影响,关于这一主题的许多流行病学研究都证明了这一点。酒精对心血管并发症的影响不仅受饮酒量的影响,还受饮酒模式的影响(酗酒与定期适量饮酒)。这也适用于饮酒与血压升高或动脉高血压发展之间的关系。
{"title":"Alcohol and the cardiovascular system.","authors":"Jitka Mlíková Seidlerová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mlíková Seidlerová J. Alcohol and the cardiovascular system The consumption of alcohol leads to a variety of direct and indirect effects on the cardiovascular system, as evidenced by numerous epidemiological studies on this topic. The effect of alcohol on the development of cardiovascular complications is influenced not only by the amount of alcohol consumed but also by the drinking pattern (binge drinking vs. regular consumption of moderate amounts of alcohol). This applies to the relationship between alcohol consumption and the rise in blood pressure or the development of arterial hypertension as well.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"294-298"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The last ten years with inosine pranobex - from an "old" therapeutic agent to vaccine research, including anti-cancer vaccines. 近十年来,肌苷pranobex从一种“老”的治疗剂发展到包括抗癌疫苗在内的疫苗研究。
Q4 Medicine Pub Date : 2025-01-01
Jiří Beran, Jiří Slíva

Inosine pranobex (IP), also known as inosine pranobex dimepranol, is an immunomodulatory drug with a history spanning more than fifty years. It was first introduced in the 1970s and has since been licensed in more than 50 countries around the world. It was originally considered a potential drug for AIDS, which raised high hopes at the time of the discovery of the HIV virus. However, after initial interest, its use in this area declined, and for a long time, IP was no longer discussed significantly in professional literature or clinical practice. Renewed interest came only in the last decade, when IP began to reappear in connection with the treatment of acute respiratory infections, diseases caused by human papillomavirus (HPV), and other viral diseases, including COVID-19. It also began to be used as an adjuvant in the foot-and-mouth disease vaccine, and research began on an IP-based anti-tumor vaccine.

肌苷pranobex (Inosine pranobex, IP)又称肌苷pranobex dimepranol,是一种具有50多年历史的免疫调节药物。它于20世纪70年代首次推出,此后已在全球50多个国家获得许可。它最初被认为是一种潜在的治疗艾滋病的药物,在发现艾滋病毒时,人们对它寄予厚望。然而,在最初的兴趣之后,它在这一领域的使用下降了,很长一段时间,IP不再在专业文献或临床实践中得到显著的讨论。直到最近十年,知识产权才重新引起人们的兴趣,当时知识产权开始重新出现在急性呼吸道感染、人乳头瘤病毒(HPV)引起的疾病和其他病毒性疾病(包括COVID-19)的治疗中。它也开始被用作口蹄疫疫苗的佐剂,并开始研究基于ip的抗肿瘤疫苗。
{"title":"The last ten years with inosine pranobex - from an \"old\" therapeutic agent to vaccine research, including anti-cancer vaccines.","authors":"Jiří Beran, Jiří Slíva","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Inosine pranobex (IP), also known as inosine pranobex dimepranol, is an immunomodulatory drug with a history spanning more than fifty years. It was first introduced in the 1970s and has since been licensed in more than 50 countries around the world. It was originally considered a potential drug for AIDS, which raised high hopes at the time of the discovery of the HIV virus. However, after initial interest, its use in this area declined, and for a long time, IP was no longer discussed significantly in professional literature or clinical practice. Renewed interest came only in the last decade, when IP began to reappear in connection with the treatment of acute respiratory infections, diseases caused by human papillomavirus (HPV), and other viral diseases, including COVID-19. It also began to be used as an adjuvant in the foot-and-mouth disease vaccine, and research began on an IP-based anti-tumor vaccine.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 7-8","pages":"321-323"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Surgery Clinic in Hradec Králové. 赫拉德克心脏外科诊所Králové。
Q4 Medicine Pub Date : 2025-01-01
Jan Harrer, Pavel Žáček
{"title":"Cardiac Surgery Clinic in Hradec Králové.","authors":"Jan Harrer, Pavel Žáček","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"164 5","pages":"233-235"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Casopis lekaru ceskych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1